Erik Tambuyzer

Direktor/Vorstandsmitglied bei Augustine Therapeutics NV

Health Services

Consumer Services

Aktive Positionen von Erik Tambuyzer

Unternehmen	Position	Beginn	Ende
Augustine Therapeutics NV Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020.	Direktor/Vorstandsmitglied	19.03.2021	-

Katholieke Universiteit Leuven

Doctorate Degree

International

Belgien

Operativ

Director/Board Member	1
Doctorate Degree	1

Sektoral

Health Services	2
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	1
Augustine Therapeutics NV Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020.	Health Services

Private Unternehmen

Health Services